Clinical Trials Browser

Phase 1 × INDUSTRY × GC1118 × Clear all

NCT02352571 2016-07-06

Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

Phase 1 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms